France ships 11 tonnes of drugs to Lebanon
France's pharmaceutical trade association, Les Entreprises du Medicament (LEEM), has shipped 10.5 tonnes of drugs to the Lebanese government under the LEEM's Tulipe urgent aid program. The shipment represents the second donation by French drugmakers since the recent Middle East crisis and follows an appeal by Lebanon's Ministry of Health.
In a statement, the LEEM said that 74 palettes of essential medicines were made available by French drug companies. They were flown to Lanarca in Cyprus, before being transported by sea to Beirut, the Lebanese capital. The Tulipe program was established by the LEEM in 1982.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze